Ask AI
ProCE Banner Activity

Preparing for the Future: Integration of Second-line Therapies After Hydroxyurea for PV and ET

Slideset

Downloadable slideset on second-line treatment options for patients with PV or ET. The key evidence informing current guideline recommendations for therapy selection and data on novel therapies poised to affect later-line treatment approaches is included.

Released: April 29, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Merck Sharp & Dohme LLC.

Merck Sharp & Dohme LLC

Target Audience

This activity is intended for hematologists and other healthcare professionals caring for patients with essential thrombocythemia and polycythemia vera.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Prepare to integrate emerging second-line therapies into clinical practice for patients with ET or PV who are intolerant or resistant to front-line therapy.